- Udyam number
- UDYAM-TS-02-0037898

About Bhasya International Private Limited
Data last updated:
Bhasya International Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2020PTC142949. Its GSTIN is 36AAJCB2675G1ZK (Telangana).
The company has an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.3 Cr. It is led by directors including Jaya Sai Yarlagadda and Sravani Koratana.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹59.51 Cr, a growth of 124% compared to the previous year. For the same year it recorded a net profit of ₹92.04 Lakh (net margin 1.5%) and EBITDA of ₹1.57 Cr (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 545% over three years.
The company is associated with 1 brand: Bhasya International. As per MCA filings, the company has open charges of ₹3.7 Cr on record.
Bhasya International Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0037898). For more details, the company can be reached via its website bhasyainternational.com.
Company details
Recognitions & Rankings of Bhasya International
Contact details
Bhasya International Private Limited's registered office is in Hyderabad, Telangana. Its website is bhasyainternational.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 293 12 – 12 – 933/11, Flat No – 201 Nakkoda Arcade, Hyderabad, Telangana, India – 500018
- IndustryPharma, API Manufacturers
To see the full contact details of Bhasya International Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bhasya International operates one associated brand: Bhasya International. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, supplying, and exporting of APIs, excipients, and related materials in India. | bhasyainternational.com |
Business activity
The main business activity of Bhasya International is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bhasya International Private Limited, buy the company report.
Financials of Bhasya International Private Limited
FY 2024 filings availableBhasya International Private Limited reported revenue of ₹59.51 Cr (up 124% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 545% over three years, including 124% growth in the latest year. EBITDA rose 368% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.57 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹92.04 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.6% | |||
| Net Profit Margin | 1.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bhasya International Private Limited, buy the company report.
Board of directors of Bhasya International Private Limited
Bhasya International has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaya Sai Yarlagadda | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Sravani Koratana | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Bhaskara Rao Akkapolu Also directs: Srinag Pharma Private Limited | Director | 12 Feb 2024 | 2 Years 9 Months | Current |
| Veera Basava Shivakumari Samatham Also directs: Srinag Pharma Private Limited | Additional Director | 12 Feb 2024 | 2 Years 9 Months | Current |
| Syam Kumar Kokku Also directs: Srinag Pharma Private Limited | Additional Director | 12 Feb 2024 | 2 Years 9 Months | Current |
Peer comparison
Bhasya International Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Androst Biotech India Private Limited | ₹61.85 Cr (FY 2025) | -12.0% | Anand, Gujarat, India | |||
| Saptagir Laboratories Private Limited | ₹60.25 Cr (FY 2025) | 8.0% | Hyderabad, Telangana, India | |||
| Cadchem Laboratories Limited | ₹59.73 Cr (FY 2024) | -13.0% | Chandigarh, India | |||
| Macsen Labs Limited | ₹59.7 Cr (FY 2025) | -9.0% | Udaipur, Rajasthan, India | |||
| Bhasya International Private Limitedthis company | ₹59.51 Cr (FY 2024) | ₹92.04 Lakh | 1.5% | 124.0% | Hyderabad, Telangana, India | |
| Vaasavaa Pharmaceuticals Private Limited | ₹59.28 Cr (FY 2025) | 16.0% | Solapur, Maharashtra, India | |||
| Venus Chemicals and Drugs Private Limited | ₹59.13 Cr (FY 2025) | 66.0% | Hyderabad, Telangana, India | |||
| Vivachem Intermediates Private Limited | ₹59.12 Cr (FY 2025) | 84.0% | Raikot, Punjab, India |
To see the full peer comparison of Bhasya International Private Limited, buy the company report.
Auditor
Bhasya International Private Limited is audited by N R REDDY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N R REDDY & ASSOCIATES | FY 2023 | 240949 |
Shareholding
The shareholding of Bhasya International Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bhasya International Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Feb 2024 | 100908767 | Hdfc Bank Limited | ₹15.59 Lakh | Open | |
| 13 Feb 2024 | 100905683 | Hdfc Bank Limited | ₹29.11 Lakh | Open | |
| 23 Jun 2023 | 100795727 | Others | ₹3.25 Cr | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Bhasya International Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bhasya International Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bhasya International has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCB2675G1ZK | Telangana | Active | 16 Oct 2020 |
To see the full GST registrations and return filing status of Bhasya International Private Limited, buy the company report.
Recent activity
Bhasya International Private Limited has 5 board changes on record since 2020: 5 appointments. The latest: Bhaskara Rao Akkapolu was appointed as Director on 12 Feb 2024.
Frequently asked questions
Bhasya International is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 August 2020 (6+ years old) and is registered under CIN U51909TG2020PTC142949.
Bhasya International has 5 current directors:
- Jaya Sai Yarlagadda - Director
- Sravani Koratana - Director
- Bhaskara Rao Akkapolu - Director
- Veera Basava Shivakumari Samatham - Additional Director
- Syam Kumar Kokku - Additional Director
The latest financial statements of Bhasya International on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Bhasya International is 36AAJCB2675G1ZK, registered in Telangana.
The CIN (Corporate Identification Number) of Bhasya International is U51909TG2020PTC142949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bhasya International was incorporated on 19 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Bhasya International by revenue are Androst Biotech India Private Limited, Saptagir Laboratories Private Limited, Cadchem Laboratories Limited, Macsen Labs Limited, Vaasavaa Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhaskara Rao Akkapolu was appointed as Director on 12 Feb 2024. Syam Kumar Kokku was appointed as Additional Director on 12 Feb 2024. Veera Basava Shivakumari Samatham was appointed as Additional Director on 12 Feb 2024. Bhasya International has 5 board changes on record in total.
Yes, Bhasya International is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0037898).
Bhasya International can be reached through the website bhasyainternational.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Bhasya International is at Plot No – 293 12 – 12 – 93311, Flat No – 201 Nakkoda Arcade, Hyderabad, Telangana, India – 500018.

